uEXPLORER Total-body PET/CT in Nasopharyngeal Carcinoma
NCT04394065 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 56
Last updated 2021-09-17
Summary
uEXPLORER total-body PET/CT in Nasopharyngeal Carcinoma
Conditions
- Nasopharyngeal Carcinoma
Interventions
- DEVICE
-
ultrasensitive positron emission tomography
A 194-cm-long total-body positron emission tomography/computed tomography (PET/CT) scanner (uEXPLORER)
Sponsors & Collaborators
-
Sun Yat-sen University
lead OTHER
Principal Investigators
-
Haiqiang Mai, Dr · Sun Yat-sen University
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-06-20
- Primary Completion
- 2021-02-20
- Completion
- 2021-06-20
- FDA Device
- Yes
Countries
- China
Study Locations
More Related Trials
-
Clinical Efficacy of Stereotactic Radiotherapy and Microwave Ablation for Liver Metastases From Colorectal Cancer.
NCT03963726 ·Status: UNKNOWN ·Phase: NA
-
High Dose Radiotherapy for the Treatment of Rectal Cancer
NCT03541304 ·Status: COMPLETED
-
Radiotherapy With Neoadjuvant Chemotherapy and Immunotherapy in Rectal Cancer
NCT04558684 ·Status: SUSPENDED ·Phase: PHASE1/PHASE2
-
68Ga-FAPI-04 PET Imaging in Early Response Evaluation of Rectal Cancer Patients Treated With Immunotherapy
NCT05999227 ·Status: UNKNOWN ·Phase: NA
-
High-activity Natural Killer Immunotherapy for Small Metastases of Colorectal Cancer
NCT03008499 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Consolidative Radiotherapy Plus Maintenance Chemotherapy for Metastatic Colorectal Cancer
NCT03142282 ·Status: UNKNOWN ·Phase: PHASE2
-
Application of Amide Proton Transfer-Weighted Imaging in Predicting Pathological Complete Response After Neoadjuvant Therapy of Rectal Cancer
NCT06719414 ·Status: RECRUITING
-
Safety and Efficacy of CEA-Targeted CAR-T Therapy for Relapsed/Refractory CEA+ Cancer
NCT04348643 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
PET-CT and Circulating Tumor Cells in Colorectal Cancer
NCT01163305 ·Status: COMPLETED
-
Computed Tomography-guided Brachytherapy Plus Chemotherapy for Locally Recurrent Rectum Cancer
NCT02423226 ·Status: COMPLETED ·Phase: PHASE2
-
Therapeutic Study of 177Lu-CTR-FAPI in Advanced Metastatic Digestive Malignancies
NCT07014254 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
TNT to Increase the Clinical Complete Response Rate for Distal LARC
NCT03840239 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
The Clinical Outcome and the Exploration of Related Biomarkers of Target Therapy in Metastasis Colorectal Cancer
NCT02523495 ·Status: UNKNOWN
-
Exploratory Study of Intermittent Hypoxia Intervention on Colorectal Cancer
NCT06584318 ·Status: RECRUITING ·Phase: NA
-
68Ga-NYM096/177Lu-NYM096 in Metastatic ccRCC
NCT06649682 ·Status: SUSPENDED ·Phase: PHASE1
-
A Prospective Cohort Study of Advanced Colorectal Cancer Treated With Oxaliplatin and Irinotecan.
NCT05731336 ·Status: RECRUITING
-
The Function of PA, RBP and TRSF in Malnutrition Detecting and Nutritional Status Monitoring for NPC Patients
NCT03240835 ·Status: COMPLETED
-
Survival Benefit of Compound Kushen Injection in the Treatment of Advanced Colorectal Cancer
NCT05894694 ·Status: RECRUITING ·Phase: PHASE4
-
Consolidative Radiotherapy for Colorectal Cancer Liver Metastases Receiving Surgery or Radiofrequency Ablation
NCT03135652 ·Status: WITHDRAWN ·Phase: PHASE2
-
Diagnostic Value of Whole-Body MRI for Rectal Cancer Preoperative Staging
NCT01745874 ·Status: UNKNOWN
-
Predicting Neoadjuvant Therapy Response of Rectal Cancer With MRI
NCT02640586 ·Status: UNKNOWN ·Phase: NA
-
Application of MR-PET in Colorectal Cancer
NCT02553031 ·Status: UNKNOWN
-
[68Ga]Ga-GZP PET for Early Response Prediction in Colorectal Cancer During Neoadjuvant Therapy
NCT06982053 ·Status: COMPLETED ·Phase: NA
-
MDT to Evaluate the Survival Benefit of Patients With Advanced Gastric / Colorectal Cancer
NCT03400657 ·Status: UNKNOWN
-
Radical Concurrent Chemoradiotherapy With DDP/5-FU and PD-1 Antibody for Non-metastatic Rectal Squamous Cell Carcinoma
NCT06364384 ·Status: RECRUITING ·Phase: PHASE2